+
データを開く
-
基本情報
登録情報 | データベース: PDB / ID: 1ogw | ||||||
---|---|---|---|---|---|---|---|
タイトル | Synthetic Ubiquitin with fluoro-Leu at 50 and 67 | ||||||
![]() | UBIQUITIN | ||||||
![]() | CELL CYCLE / CHROMOSOMAL PROTEIN | ||||||
機能・相同性 | ![]() Maturation of protein E / Maturation of protein E / ER Quality Control Compartment (ERQC) / Myoclonic epilepsy of Lafora / FLT3 signaling by CBL mutants / Prevention of phagosomal-lysosomal fusion / IRAK2 mediated activation of TAK1 complex / Alpha-protein kinase 1 signaling pathway / Glycogen synthesis / IRAK1 recruits IKK complex ...Maturation of protein E / Maturation of protein E / ER Quality Control Compartment (ERQC) / Myoclonic epilepsy of Lafora / FLT3 signaling by CBL mutants / Prevention of phagosomal-lysosomal fusion / IRAK2 mediated activation of TAK1 complex / Alpha-protein kinase 1 signaling pathway / Glycogen synthesis / IRAK1 recruits IKK complex / IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation / Endosomal Sorting Complex Required For Transport (ESCRT) / Membrane binding and targetting of GAG proteins / Negative regulation of FLT3 / Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 / PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 / Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation / Constitutive Signaling by NOTCH1 HD Domain Mutants / IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation / NOTCH2 Activation and Transmission of Signal to the Nucleus / TICAM1,TRAF6-dependent induction of TAK1 complex / TICAM1-dependent activation of IRF3/IRF7 / APC/C:Cdc20 mediated degradation of Cyclin B / Downregulation of ERBB4 signaling / Regulation of FZD by ubiquitination / APC-Cdc20 mediated degradation of Nek2A / p75NTR recruits signalling complexes / InlA-mediated entry of Listeria monocytogenes into host cells / TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling / TRAF6-mediated induction of TAK1 complex within TLR4 complex / Regulation of pyruvate metabolism / NF-kB is activated and signals survival / Regulation of innate immune responses to cytosolic DNA / Downregulation of ERBB2:ERBB3 signaling / Pexophagy / NRIF signals cell death from the nucleus / VLDLR internalisation and degradation / Regulation of PTEN localization / Activated NOTCH1 Transmits Signal to the Nucleus / Synthesis of active ubiquitin: roles of E1 and E2 enzymes / Regulation of BACH1 activity / MAP3K8 (TPL2)-dependent MAPK1/3 activation / TICAM1, RIP1-mediated IKK complex recruitment / Translesion synthesis by REV1 / InlB-mediated entry of Listeria monocytogenes into host cell / Translesion synthesis by POLK / Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) / Downregulation of TGF-beta receptor signaling / JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 / Josephin domain DUBs / Translesion synthesis by POLI / IKK complex recruitment mediated by RIP1 / Regulation of activated PAK-2p34 by proteasome mediated degradation / Gap-filling DNA repair synthesis and ligation in GG-NER / PINK1-PRKN Mediated Mitophagy / TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) / TNFR1-induced NF-kappa-B signaling pathway / Autodegradation of Cdh1 by Cdh1:APC/C / APC/C:Cdc20 mediated degradation of Securin / TCF dependent signaling in response to WNT / N-glycan trimming in the ER and Calnexin/Calreticulin cycle / Regulation of NF-kappa B signaling / Asymmetric localization of PCP proteins / activated TAK1 mediates p38 MAPK activation / Ubiquitin-dependent degradation of Cyclin D / SCF-beta-TrCP mediated degradation of Emi1 / NIK-->noncanonical NF-kB signaling / TNFR2 non-canonical NF-kB pathway / AUF1 (hnRNP D0) binds and destabilizes mRNA / Regulation of signaling by CBL / NOTCH3 Activation and Transmission of Signal to the Nucleus / Negative regulators of DDX58/IFIH1 signaling / Vpu mediated degradation of CD4 / Deactivation of the beta-catenin transactivating complex / Assembly of the pre-replicative complex / Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A / Degradation of DVL / Negative regulation of FGFR3 signaling / Fanconi Anemia Pathway / Peroxisomal protein import / Dectin-1 mediated noncanonical NF-kB signaling / Cdc20:Phospho-APC/C mediated degradation of Cyclin A / Negative regulation of FGFR2 signaling / Negative regulation of FGFR4 signaling / Stabilization of p53 / Degradation of AXIN / Downregulation of SMAD2/3:SMAD4 transcriptional activity / Negative regulation of FGFR1 signaling / Regulation of TNFR1 signaling / Hh mutants are degraded by ERAD / Activation of NF-kappaB in B cells / EGFR downregulation / Termination of translesion DNA synthesis / Degradation of GLI1 by the proteasome / G2/M Checkpoints / SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription / Iron uptake and transport / Hedgehog ligand biogenesis / Defective CFTR causes cystic fibrosis / GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 類似検索 - 分子機能 | ||||||
生物種 | ![]() | ||||||
手法 | ![]() ![]() ![]() | ||||||
![]() | Alexeev, D. / Ramage, R. / Young, D.W. / Sawyer, L. | ||||||
![]() | ![]() タイトル: Synthesis, Structural and Biological Studies of Ubiquitin Mutants Containing (2S, 4S)-5-Fluoroleucine Residues Strategically Placed in the Hydrophobic Core 著者: Alexeev, D. / Barlow, P.N. / Bury, S.M. / Charrier, J.-D. / Cooper, A. / Hadfield, D. / Jamieson, C. / Kelly, S.M. / Layfield, R. / Mayer, R.J. / Mcsparran, H. / Price, N.C. / Ramage, R. / ...著者: Alexeev, D. / Barlow, P.N. / Bury, S.M. / Charrier, J.-D. / Cooper, A. / Hadfield, D. / Jamieson, C. / Kelly, S.M. / Layfield, R. / Mayer, R.J. / Mcsparran, H. / Price, N.C. / Ramage, R. / Sawyer, L. / Starkmann, B.A. / Uhrin, D. / Willken, J. / Young, D.W. #1: ジャーナル: Biochem.J. / 年: 1994 タイトル: Synthetic, Structural and Biological Studies of the Ubiquitin System 著者: Alexeev, D. / Bury, S.M. / Turner, M.A. / Ogunjobi, O.M. / Muir, T.W. / Ramage, R. / Sawyer, L. #2: ジャーナル: Biochem.J. / 年: 1997 タイトル: Synthetic, Structural and Biological Studies of the Ubiquitin System: The Synthesis and Crystal Structu of an Analogue Containing Unnatural Amino Acids 著者: Love, S.G. / Muir, T.W. / Ramage, R. / Shaw, K.T. / Alexeev, D. / Sawyer, L. / Kelly, S.M. / Price, N.C. / Arnold, J.E. / Lee, M.P. / Mayer, R.J. #3: ![]() タイトル: Structure of ubiquitin refined at 1.8 A resolution. 要旨: The crystal structure of human erythrocytic ubiquitin has been refined at 1.8 A resolution using a restrained least-squares procedure. The crystallographic R-factor for the final model is 0.176. Bond ...The crystal structure of human erythrocytic ubiquitin has been refined at 1.8 A resolution using a restrained least-squares procedure. The crystallographic R-factor for the final model is 0.176. Bond lengths and bond angles in the molecule have root-mean-square deviations from ideal values of 0.016 A and 1.5 degrees, respectively. A total of 58 water molecules per molecule of ubiquitin are included in the final model. The last four residues in the molecule appear to have partial occupancy or large thermal motion. The overall structure of ubiquitin is extremely compact and tightly hydrogen-bonded; approximately 87% of the polypeptide chain is involved in hydrogen-bonded secondary structure. Prominent secondary structural features include three and one-half turns of alpha-helix, a short piece of 3(10)-helix, a mixed beta-sheet that contains five strands, and seven reverse turns. There is a marked hydrophobic core formed between the beta-sheet and alpha-helix. The molecule features a number of unusual secondary structural features, including a parallel G1 beta-bulge, two reverse Asx turns, and a symmetrical hydrogen-bonding region that involves the two helices and two of the reverse turns. | ||||||
履歴 |
|
-
構造の表示
構造ビューア | 分子: ![]() ![]() |
---|
-
ダウンロードとリンク
-
ダウンロード
PDBx/mmCIF形式 | ![]() | 30.6 KB | 表示 | ![]() |
---|---|---|---|---|
PDB形式 | ![]() | 20 KB | 表示 | ![]() |
PDBx/mmJSON形式 | ![]() | ツリー表示 | ![]() | |
その他 | ![]() |
-検証レポート
文書・要旨 | ![]() | 395.3 KB | 表示 | ![]() |
---|---|---|---|---|
文書・詳細版 | ![]() | 397.1 KB | 表示 | |
XML形式データ | ![]() | 4.1 KB | 表示 | |
CIF形式データ | ![]() | 5.6 KB | 表示 | |
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
-関連構造データ
関連構造データ | ![]() 1ubiS S: 精密化の開始モデル |
---|---|
類似構造データ |
-
リンク
-
集合体
登録構造単位 | ![]()
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
単位格子 |
|
-
要素
#1: タンパク質 | 分子量: 8612.812 Da / 分子数: 1 / 断片: RESIDUES 1-76 / 由来タイプ: 天然 / 詳細: LEF IS (4S)-5-FLUORO-L-LEUCINE / 由来: (天然) ![]() |
---|---|
#2: 水 | ChemComp-HOH / |
構成要素の詳細 | LEU (50) AND LEU (67) ARE MODIFIED RESIDUES |
Has protein modification | Y |
-実験情報
-実験
実験 | 手法: ![]() |
---|
-
試料調製
結晶 | マシュー密度: 1.8 Å3/Da / 溶媒含有率: 32.68 % |
---|---|
結晶化 | pH: 5.6 詳細: SEEDED FROM DROP CONTAINING CONTAINING 5 MUL 20MG/ML UBIQUITIN AND 5 MUL 30% PEG 4000 IN 50MM CACODYLATE-HCL PH 5.6. STORED IN 38% PEG 4000. |
結晶化 | *PLUS 手法: other / 詳細: Love, S.G., (1997) Biochem. J., 323, 727. |
-データ収集
回折 | 平均測定温度: 110 K |
---|---|
放射光源 | 由来: ![]() ![]() ![]() |
検出器 | タイプ: MARRESEARCH / 検出器: IMAGE PLATE / 日付: 1999年5月15日 / 詳細: MIRRORS |
放射 | モノクロメーター: SILICON / プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 0.87 Å / 相対比: 1 |
反射 | 解像度: 1.32→6 Å / Num. obs: 13828 / % possible obs: 89.9 % / Observed criterion σ(I): 1 / 冗長度: 4.5 % / Rmerge(I) obs: 0.11 / Net I/σ(I): 10 |
反射 シェル | 解像度: 1.31→1.32 Å / 冗長度: 2.8 % / Rmerge(I) obs: 0.54 / Mean I/σ(I) obs: 2.3 / % possible all: 81.4 |
反射 | *PLUS Num. obs: 14305 / Num. measured all: 157103 |
-
解析
ソフトウェア |
| |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: ![]() 開始モデル: PDB ENTRY 1UBI 解像度: 1.32→8 Å / Num. parameters: 2814 / Num. restraintsaints: 2521 / σ(F): 0 / 立体化学のターゲット値: ENGH & HUBER /
| |||||||||||||||||||||||||||||||||
Refine analyze | Num. disordered residues: 2 / Occupancy sum hydrogen: 3212 / Occupancy sum non hydrogen: 2736 | |||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 1.32→8 Å
| |||||||||||||||||||||||||||||||||
拘束条件 |
| |||||||||||||||||||||||||||||||||
ソフトウェア | *PLUS 名称: SHELXL / バージョン: 97 / 分類: refinement | |||||||||||||||||||||||||||||||||
精密化 | *PLUS | |||||||||||||||||||||||||||||||||
溶媒の処理 | *PLUS | |||||||||||||||||||||||||||||||||
原子変位パラメータ | *PLUS |